Announcements

• DEC27
  Inside Information Proposed Asset Restructuringpdf
• DEC16
  Announcement Proposed Amendment to the Articles of Associationpdf
• DEC09
  List of Directors and Their Role and Functionpdf
• DEC09
  Announcement Resignation of Independent Non-executive Directorpdf
• NOV27
  Announcement on Postponement of Extraordinary General Meeting and Extension of Book Closure Periodpdf
• NOV18
  Supplemental Announcement to Acquisition of 20% Equity Interest in Sinopharm Holding Medical Investment from Sinopharm Industrial Investmentpdf
• NOV06
  Voluntary Announcementpdf
• NOV06
  Announcement Change of Principal Place of Business in Hong Kongpdf
• OCT27
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• OCT27
  Announcementpdf
• OCT26
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• OCT26
  Announcements and Notices - Announcement Principal Financial Data of Sinopharm Accord for the Nine Months Ended 30 September 2015pdf
• OCT20
  Announcement - Principal Financial Data of Sinopharm (CNCM Ltd) for the Nine Months Ended 30 September 2015pdf
• OCT20
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• OCT15
  Continuing Connected Transactions Entering into the Epc General Contracting Service Framework Agreementpdf
• OCT15
  Notice of Extraordinary General Meetingpdf
• OCT14
  Notice of Board Meetingpdf
• OCT13
  Connected Transaction Capital Increase Agreement Regarding Guorui Medicinepdf
• OCT13
  Proposed Amendments to the Articles of Associationpdf
• AUG24
  Announcement on 2015 Interim Resultspdf
• AUG20
  Announcement Poll Results of the Extraordinary General Meeting Held on Thursday, 20 August 2015pdf
• AUG20
  Announcement Principal Financial Data of Sinopharm Accord for the Six Months Ended 30 June 2015pdf
• AUG18
  Announcement Principal Financial Data of Sinopharm (CNCM Ltd) for the Six Months Ended 30 June 2015pdf
• AUG18
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• AUG17
  Connected Transaction Acquisition of 20% Equity Interest in Sinopharm Holding Medical Investment Management Co. from Sinopharm Investmentpdf
• AUG11
  Notice of Board Meetingpdf
• JUL03
  (Headlines Revised) Notice of Extraordinary General Meetingpdf
• JUL03
  (Cancelled since Headlines Superseded and Replaced) Notice of Extraordinary General Meetingpdf
• JUN21
  Announcement Proposed Issue of the Corporate Bondspdf
• JUN18
  Articles of Associationpdf
• JUN18
  Announcement Poll Results of the Annual General Meeting Held on Thursday, 18 June 2015 Change in Employee Representative Supervisors and Payment of the Final Dividendpdf
• APR30
  Notice of Annual General Meetingpdf
• APR27
  Proposed Amendments to the Articles of Association Proposed Appointment of independent Supervisor and Redesignation of Supervisorpdf
• APR27
  Announcementpdf
• APR27
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• APR24
  Announcement Principal Financial Data of Sinopharm (cncm Ltd)for the Three Months Ended 31 March 2015pdf
• APR24
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• APR24
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• APR24
  Announcement Principal Financial Data of Sinopharm Accord for the Three Months Ended 31 March 2015pdf
• APR15
  Notice of Board Meetingpdf
• APR10
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• MAR23
  Annual Results Announcement for the Year Ended 31 December 2014pdf
• MAR22
  Announcement Principal Financial Data of Sinopharm (CNCM Ltd) for the Year Ended 31 December 2014pdf
• MAR22
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• MAR22
  Announcement Principal Financial Data of Sinopharm Accord for the Year Ended 31 December 2014pdf
• MAR22
  Overseas Regulatory Announcement (Provide Chinese Version only)pdf
• MAR10
  Notice of Board Meetingpdf
• FEB06
  Further Announcement on Participation in the Pilot Works of Developing a Mixed-ownership Economypdf